2026-07-142 min
GHRP-6: Receptor Pathway Map and Evidence Boundaries
An evidence-led GHRP-6 review focused on receptor pathway map, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity DeskEvidence notes
Human studies, mechanisms, safety signals, regulatory status, and the limits of each conclusion.
Open
2026-07-142 min
GHRP-6: Terminology Audit and Evidence Boundaries
An evidence-led GHRP-6 review focused on terminology audit, human-study limits, regulatory context and claim verification.
Reviewed by CJC Axis Editorial Team2026-07-132 min
Sermorelin: Evidence Checklist and Evidence Boundaries
An evidence-led Sermorelin review focused on evidence checklist, human-study limits, regulatory context and claim verification.
Reviewed by Clinical Trial Review Team2026-07-132 min
Sermorelin: Research Gaps Map and Evidence Boundaries
An evidence-led Sermorelin review focused on research gaps map, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-07-132 min
Sermorelin: Glucose and Metabolic Context and Evidence Boundaries
An evidence-led Sermorelin review focused on glucose and metabolic context, human-study limits, regulatory context and claim verification.
Reviewed by Clinical Trial Review Team2026-07-132 min
Sermorelin: Healthy-Aging Claims and Evidence Boundaries
An evidence-led Sermorelin review focused on healthy-aging claims, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-122 min
Sermorelin: Sleep Claims and Evidence Boundaries
An evidence-led Sermorelin review focused on sleep claims, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-122 min
Sermorelin: Recovery and Injury Claims and Evidence Boundaries
An evidence-led Sermorelin review focused on recovery and injury claims, human-study limits, regulatory context and claim verification.
Reviewed by CJC Axis Editorial Team2026-07-122 min
Sermorelin: Body Composition Claims and Evidence Boundaries
An evidence-led Sermorelin review focused on body composition claims, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-122 min
Sermorelin: Adverse-Event Reporting and Evidence Boundaries
An evidence-led Sermorelin review focused on adverse-event reporting, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk